Less than four years after Walgreen (WAG) and rival drugstores like CVS/Caremark Corp. (CVS) began a lobbying blitz with state regulators to allow pharmacists to administer seasonal influenza shots, pharmacies are beginning to see benefits of the strategy in their bottom lines.
Less than four years after Walgreen (WAG) and rival drugstores like CVS/Caremark Corp. (CVS) began a lobbying blitz with state regulators to allow pharmacists to administer seasonal influenza shots, pharmacies are beginning to see benefits of the strategy in their bottom lines.